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Abstract 
 
To gain insight into the role of the strictly conserved histidine residue, H79, in the reaction mechanism of the 
methionyl aminopeptidase from Escherichia coli (EcMetAP-I), the H79A mutated enzyme was prepared. Co(II)-
loaded H79A exhibits an overall >7000-fold decrease in specific activity. The almost complete loss of activity is 
primarily due to a >6000-fold decrease in kcat. Interestingly, the Km value obtained for Co(II)-loaded H79A was 
approximately half the value observed for wild-type (WT) EcMetAP-I. Consequently, kcat/Km values decreased 
only 3000-fold. On the other hand, the observed specific activity of Mn(II)-loaded H79A EcMetAP-I decreased by 
∼2.6-fold while kcat decreased by ∼3.5-fold. The observed Km value for Mn(II)-loaded H79A EcMetAP-I was ∼1.4-
fold larger than that observed for WT EcMetAP-I, resulting in a kcat/Km value that is lower by ∼3.4-fold. Metal 
binding, UV−vis, and EPR data indicate that the active site is unperturbed by mutation of H79, as suggested by X-
ray crystallographic data. Kinetic isotope data indicate that H79 does not transfer a proton to the newly forming 
amine since a single proton is transferred in the transition state for both the WT and H79A EcMetAP-I enzymes. 
Therefore, H79 functions to position the substrate by hydrogen bonding to either the amine group of the 
peptide linkage or a backbone carbonyl group. Together, these data provide new insight into the catalytic 
mechanism of EcMetAP-I. 
Methionine aminopeptidases (MetAPs) are ubiquitous enzymes responsible for the cleavage of N-terminal 
methionine residues from polypeptide chains (2-5). Methionine is the universal initiator of protein synthesis, 
and the removal of methionine is critical in protein maturation processes (6, 7). The physiological importance of 
MetAP activity is underscored by the cellular lethality upon deletion of MetAP genes in Escherichia 
coli, Salmonella typhimurium, and Saccharomyces cerevisiae(8-11). Moreover, a MetAP from eukaryotes has 
been identified as the molecular target for the antiangiogenesis drugs ovalicin and fumagillin, among others (12-
16). Therefore, the inhibition of MetAP activity in tumors is an emerging therapy for the prevention of tumor 
vascularization, which often leads to tumor regression due to oxygen and nutrient deprivation. Used in 
conjunction with standard cancer therapies, including surgery, radiation, and/or chemotherapy, antiangiogenic 
drugs are used to shrink localized tumors and protect against metastasis. Targeting angiogenesis for cancer 
treatment has a number of advantages, including low cellular toxicity and a lack of drug resistance (15), since it 
is a disease-specific therapy. 
MetAPs are organized into two classes (types I and II) on the basis of the absence or presence of an extra 62-
amino acid sequence (of unknown function) inserted near the catalytic domain of type II enzymes. The type I 
MetAPs from E. coli (EcMetAP-I),1Staphylococcus aureus (SaMetAP-I), Thermotoga maritima (TmMetAP-I), 
and Homo sapiens (HsMetAP-I) and the type II MetAPs from H. sapiens (HsMetAP-II) and Pyrococcus 
furiosus (PfMetAP-II) have been crystallographically characterized (15, 17-22). All six display a novel “pita-bread” 
fold with an internal pseudo-2-fold symmetry that structurally relates the first and second halves of the 
polypeptide chain to each other. Each half contains an antiparallel β-pleated sheet that is flanked by two α-
helical segments. Both domains contribute conserved residues as ligands to the divalent metal ions residing in 
the active site. In addition, all six structures contain a bis(μ-carboxylato)(μ-aquo/hydroxo)dicobalt(II) core with 
an additional carboxylate residue at each metal site and a single histidine bound to Co1 (Figure 1) (23, 24). 
Recently, an X-ray crystal structure of EcMetAP-I was reported with only a single Mn(II) ion bound in the active 
site (25). This structure was obtained by limiting the amount of metal ion present during crystal growth. The 
beauty of this structure is that it provides the first structural verification that MetAPs can form mononuclear 
active sites and are fully active, and the single divalent metal ion resides on the H171 side of the active site as 
previously predicted by 1H NMR and EXAFS spectroscopy (23, 24). 
Abbreviations: EcMetAP-I, methionine aminopeptidase from E. coli; PfMetAP-II, methionine aminopeptidase 
from P. furiosus; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; ICP-AES, inductively coupled 
plasma atomic emission spectroscopy. 
 
Figure 1. Plot of Vn/V0 vs atom fraction of deuterium for WT (◼) and H79A (◯) EcMetAP-I at pH 7.5. Vn/V0 is 
defined as the velocity at n atom fraction of deuterium over the velocity in water. Each point is an average of 
three replicates. 
 
The catalytic roles of both the active site metal ions as well as active site residues have been proposed (1, 25-
27). However, the proposed catalytic mechanism for MetAP assigns no definitive role to the conserved histidine 
(H79; E. coli numbering), which resides ∼8 Å from the first metal binding site (26). On the basis of X-ray 
crystallographic data for both type I and II MetAPs bound by several substrate, transition state, and product 
inhibitors as well as fumagillin, H79 has been thought to help position the substrate in the active site and/or to 
transfer a proton to the newly formed N-terminal amine (15, 28). A significant aspect of designing small 
molecules that specifically target MetAPs requires a detailed understanding of how potential antiangiogenic 
inhibitors interact with MetAPs. To determine the catalytic role of H79, we have prepared the H79A 
mutant EcMetAP-I and characterized the enzyme using kinetic and spectroscopic methods. 
Materials and Methods 
Mutagenesis, Protein Expression, and Purification 
All chemicals used in this study were purchased commercially and were of the highest quality available. The 
H79A-altered EcMetAP-I enzyme was generated as previously reported (16). Recombinant WT and 
H79A EcMetAP-I were expressed and purified as previously described (29, 30). Purified H79A EcMetAP-I 
exhibited a single band on SDS−PAGE, indicating an overall purity of >95%. Protein concentrations were 
estimated from the absorbance at 280 nm using an extinction coefficient of 16450 M−1 cm−1. Apo-EcMetAP-I 
H79A samples were exchanged into 25 mM HEPES (pH 7.5) containing 150 mM KCl (Centricon-10, Millipore 
Corp.). Samples were stored frozen at −80 °C until they were needed. 
Metal Content Measurement 
The concentrations of H79A and WT EcMetAP-I samples used for metal analysis were typically 30 μM. Apo-
EcMetAP-I samples were incubated under anaerobic conditions with MCl2, where M is Co(II) or Fe(II) (MCl2, 
99.999%, Strem Chemicals, Newburyport, MA, or Aldrich, St. Louis, MO), for 30 min prior to exhaustive dialysis 
under anaerobic conditions against Chelex-100-treated buffer as previously reported (29, 30). Analyses were 
performed using inductively coupled plasma atomic emission spectrometry (ICP-AES). 
Enzymatic Assay of H79A EcMetAP-I 
H79A EcMetAP-I was assayed for catalytic activity using the tetrapeptide MGMM as the substrate (8 mM) with a 
high-performance liquid chromatography (HPLC) assay as previously described with minor modifications (30). 
The reaction mixture consisted of a 4 μL aliquot of a 100 μM enzyme solution and 3 equiv of a metal solution. 
Various concentrations of substrate were added to the enzyme solution to a final volume of 20 μL [25 mM 
HEPES in Chelex-100-treated water (pH 7.5) containing 150 mM KCl]. The reaction time was 24 h. This method is 
based on the spectrophotometric quantitation of the reaction product tripeptide, GMM, following separation on 
a C8 HPLC column (Phenomenex, Luna; 5, 4.6 Å ∼ 25 cm). The kinetic parameter v (velocity) was determined at 
pH 7.5 by quantifying the tripeptide GMM at 215 nm in triplicate. One unit of activity is defined as the amount 
of enzyme that produces 1 μmol of GMM/min. The metal binding titration reaction was carried out using the 
same conditions with titrated metal concentrations of up to 10 equiv using either Co(II) or Mn(II). 
Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) measurements were conducted using a MicroCal OMEGA ultrasensitive 
titration calorimeter. The titrant (CoCl2) and apo-WT and H79A EcMetAP-I solutions were prepared in Chelex-
100-treated 25 mM HEPES buffer (pH 7.5) containing 150 mM KCl. Stock buffer solutions were thoroughly 
degassed before each titration. The enzyme solution (70 μM) was placed in the calorimeter cell and stirred at 
200 rpm to ensure rapid mixing. Typically, 3 μL of titrant was delivered over 7.6 s with a 5 min interval between 
injections to allow for complete equilibration. Each titration was continued until 4.5−6 equiv of Co(II) had been 
added to ensure that no additional complexes were formed in excess titrant. A background titration, consisting 
of the identical titrant solution but only the buffer solution in the sample cell, was subtracted from each 
experimental titration to account for the heat of dilution. These data were analyzed with a two- or three-site 
binding model using the Windows-based Origin software package supplied by MicroCal. 
Spectroscopic Measurements 
Electronic absorption spectra were recorded using a Shimadzu UV-3101PC spectrophotometer. All apo-
EcMetAP-I samples used in spectroscopic measurements were thoroughly degassed prior to incubation with 
Co(II) (CoCl2) for ∼20 min at 25 °C. Co(II)-containing samples were handled throughout in an anaerobic glovebox 
(N2/5% H2, 1 ppm O2; Coy Laboratories). Electronic absorption spectra were normalized for protein 
concentration and the absorption due to uncomplexed Co(II) (512 nm = 6.0 M−1 cm−1). Low-temperature EPR 
spectroscopy was performed using a Bruker ESP-300E spectrometer equipped with an ER 4116 DM dual-mode X-
band cavity and an Oxford Instruments ESR-900 helium flow cryostat. 
Solvent Isotope Effect 
All buffers were prepared from a freshly opened bottle of 99.9% [2H]H2O (Aldrich). The buffers and Co(II) salts 
used in the preparation of all deuterated buffers were in the anhydrous form. The pHs of all the buffers used 
were adjusted via addition of NaOD or DCl [both at 99% deuterium content (Acros Organics, Geel, Belgium)] and 
corrected for deuteration by adding 0.4 to the reading of the pH electrode (p2H = p1H meter reading + 0.4) (31). 
The kinetic assay was performed as previously described with the exception of the replacement of H2O with D2O. 
Results 
Metal Content and Specific Activity of H79A EcMetAP-I 
The number of tightly bound divalent metal ions was determined for H79A EcMetAP-I by ICP-AES. Apoenzyme 
samples (30 μM), to which 2−30 equiv of Co(II) had been added under anaerobic conditions, were dialyzed for 3 
h at 4 °C with Chelex-100-treated, metal-free HEPES buffer [25 mM HEPES and 150 mM KCl (pH 7.5)]. ICP-AES 
revealed 1.0 ± 0.1 equiv of cobalt-associated H79A-altered EcMetAP-I, similar to the amount of WT EcMetAP-
I (23). 
The specific activity of H79A EcMetAP-I was determined with the tetrapeptide substrate MGMM. Since the H79A 
enzyme was stored as the apo form, it was preincubated with 3 equiv of Co(II) for ∼30 min prior to all kinetic 
experiments. The apo form of H79A EcMetAP-I was catalytically inactive. Kinetic parameters were determined 
for Co(II)- and Mn(II)-loaded H79A and WT EcMetAP-I (Table 1). Co(II)-loaded H79A exhibits an overall >7000-
fold decrease in specific activity. The almost complete loss of activity is primarily due to a >6000-fold decrease 
in kcat. Interestingly, the Km value obtained for Co(II)-loaded H79A was approximately half the value observed for 
WT EcMetAP-I. Consequently, kcat/Km values decreased only 3000-fold. Kinetic parameters were also determined 
for Mn(II)-loaded H79A and WT EcMetAP-I (Table 1). For Mn(II)-loaded H79A EcMetAP-I, the specific activity 
decreased by ∼2.6-fold while kcat decreased by ∼3.5-fold. The observed Km value for Mn(II)-loaded 
H79A EcMetAP-I was only ∼1.4 times larger than that observed for WT EcMetAP-I, resulting in a kcat/Km value 
that is lower by only ∼3.4-fold. 
Table 1. Kinetic Parameters for H79A EcMetAP-I toward MGMM in the Presence of 3 equiv of Mn(II) or Co(II) 
at pH 7.5 
metal ion kinetic parameter wild type H79A 
Co(II) Km (mM) 3.2 ± 0.1 1.5 ± 0.1 
  kcat (s−1) 18.3 ± 0.1 0.003 ± 0.001 
  kcat/Km (M−1 s−1) 5720 2 
Mn(II) Km (mM) 1.3 ± 0.2 1.8 ± 0.1 
  kcat (s−1) 4.6 ± 0.1 1.8 ± 0.1 
  kcat/Km (M−1 s−1) 3500 1000 
 
Solvent Isotope Effect 
The solvent isotope effect was determined for both WT and H79A EcMetAP-I using MGMM as the substrate at 
pH 7.6. kcat values for MGMM were measured at several ratios of D2O and H2O, and the results were plotted as 
the atom fraction of deuterium versus Vn/V0, where Vn is the observed velocity at n fraction of deuterium 
and V0 is the observed velocity in water (Figure 1). Proton inventories were obtained by fitting the experimental 
data to equations derived from the Gross-Butler equation (eq 1): 
𝑉𝑛 𝑉0⁄ =
∏ (1 − 𝑛 + 𝑛𝜑𝑖
T)
𝑣T
𝑖
∏ (1 − 𝑛 + 𝑛𝜑𝑗
R)
𝑣T
𝑖
 
(1) 
where n is the atom fraction of deuterium, Vn and V0 are the same as described above, vT is the number of 
protons transferred in the transition state, vR is the number of protons transferred in the reactant state, and ϕ is 
the fractionation factor defined as 
𝜑 = (𝑋𝑖
D/𝑋𝑖
H)/[𝑛/(1 − 𝑛)] 
(2) 
where XiD and XiH are the mole fractions of deuterons and protons in the ith transition or reactant state, 
respectively, while the subscripts T and R refer to the transition and reactant state, respectively (32, 33). At pH 
7.6, the best fit for both WT and H79A EcMetAP-I exhibited linearity, suggesting that one proton is transferred in 
the transition state of the catalytic reaction (Figure 1). The fit yielded fractionation factors of 0.80 and 0.79 for 
WT and H79A EcMetAP-I, respectively. 
Since the largest deviations for theoretical proton inventory curves occur at atom fractions of 0.5 (34, 35), 
calculation of the midpoint partial solvent isotope effect can provide insight into the number of protons involved 
in the catalytic reaction. The following equations, derived by Elrod (34), allowed for the calculation of midpoint 
partial solvent isotope effects when the experimental data were obtained at different atom fractions: 
one protons  𝑉m ⁄ 𝑉1) = (1 −  𝑛m)(𝑉0 ⁄ 𝑉1)  +  𝑛m 
(3) 
two protons (𝑉m 𝑉1⁄ ) =  [(1 −  𝑛m)(𝑉0 ⁄ 𝑉1)
1⁄2   +  𝑛m]
2  
(4) 
general solvation (𝑉m 𝑉1⁄ ) =  (𝑉0 ⁄ 𝑉1)
(1 − 𝑛m)  
(5) 
where nm = 0.49 (the H2O/D2O ratio at the midpoint), Vm/V1 equals the midpoint partial solvent isotope effect, 
and V0/V1 represents the total isotope effect (velocity in 100% H2O/velocity in 100% D2O). The experimental and 
calculated midpoint partial isotope effects are presented in Table 2. At pH 7.6, comparison of the theoretical and 
experimental midpoint partial isotope effects for both WT and H79 EcMetAP-I suggests that one proton is 
transferred at this pH. However, the midpoint partial solvent isotope effect calculations could not strongly 
distinguish between one proton transfer and general solvation effects (Table 2). 
Table 2. Midpoint Solvent Isotope Effect Data for WT and H79A EcMetAP-I Using MGMM as the Substratea 
      calculated midpoint 
solvent isotope effect 
  
enzym
e 
V0/V
1 
midpoint solvent isotope effect 
(Vm/V1) 
one proton two 
protons 
general 
solvation 
WT 1.6 1.26 1.27 1.28 1.25 
H79A 1.5 1.17 1.21 1.24 1.22 
aExperimental and theoretical midpoint isotope effects were calculated for a 0.49 atom fraction of deuterium. 
 
Metal Binding Properties of H79A EcMetAP-I 
To examine the metal binding properties of the H79A EcMetAP-I enzyme, we titrated Mn(II) and Co(II) into apo-
H79A EcMetAP-I (Figure 2). The dissociation constant (Kd) for the first divalent metal binding event for both 
Mn(II) and Co(II) was obtained by fitting these titration data to eq 6(36): 
𝑟 =  𝑝𝐶s ⁄ (𝐾d  +  𝐶s) 
(6) 
where p is the number of sites for which interaction with M(II) is governed by the intrinsic dissociation 
constant Kd and r is the binding function calculated by conversion of the fractional saturation (fa) using eq 7 as 
previously described (23). 
𝑟 =  𝑓a 𝑝 
(7) 
Cs, the free metal concentration, was calculated using eq 8 
𝐶s = 𝐶TS  −  𝑟𝐶A 
(8) 
where CTS and CA are the total molar concentrations of metal and enzyme, respectively. Kd values were obtained 
for both Mn(II) and Co(II) by fitting these data via an iterative process that allowed both Kd and p to vary 
(Figure 2). The best fits obtained provided p values of ∼1 and Kd values of 0.4 ± 0.1 and 0.5 ± 0.1 μM for Mn(II) 
and Co(II) binding, respectively. 
 
Figure 2. Plot of binding function r vs Cs (the free metal ion concentration) for Co(II) and Mn(II) binding to 
H79A EcMetAP-I. The solid lines represent the theoretical fit to the data using eq 1. These fits provide a p value 
of ∼1 and Kd values of 0.5 ± 0.1 and 0.4 ± 0.1 μM for Co(II) and Mn(II), respectively. The inset shows a plot of 
specific activity (units per milligram) vs equivalents of Co(II) and Mn(II). All activity assays were conducted using 
8 mM MGMM in 25 mM HEPES (pH 7.5) and 150 mM KCl. 
 
In addition, isothermal titration calorimetry (ITC) was employed to determine the association constants (Ka) for 
both Co(II) and Mn(II) binding to H79A EcMetAP-I at 25.0 ± 0.2 °C (Figure 3). Ka values were obtained by fitting 
the ITC data, after subtraction of the background heat of dilution, via an iterative process using Origin. This 
software package uses a nonlinear least-squares algorithm that allows the concentrations of the titrant and the 
sample to be fit to the heat flow per injection to an equilibrium binding equation for two sets of noninteracting 
sites. The Ka value, the metal/enzyme stoichiometry (n), and the change in enthalpy (ΔH°) were allowed to vary 
during the fitting process (Table 3 and Figure 3). The relationship between Ka and the dissociation constant is 
defined as 
𝐾d  =  1 ⁄  𝐾a 
(9) 
The best fits obtained for H79A EcMetAP-I provided an overall n value of 3, indicating three noninteracting sites. 
Attempts to fit these data with n values of 1 or 2 provided poor fits. For Co(II) and Mn(II) binding to 
H79A EcMetAP-I, the observed Kd values for the first binding event are 1.4 ± 1.5 and 5.3 ± 1.4 μM, respectively, 
which are within error of those observed for WT EcMetAP-I. The second and third metal binding events are 
equivalent for H79A EcMetAP-I and provided Kd values of 1.6 ± 0.8 and 0.08 ± 0.02 mM for Co(II) and Mn(II), 
respectively. 
 
Figure 3. Isothermal titration calorimetry (ITC) titrations of 70 μM solutions of H79A EcMetAP-I with 5 mM Co(II) 
(A) or 5 mM Mn(II) (C). The best fits of the data in panels A and C are shown in panels B and D, respectively, after 
subtraction of the heat of dilution. 
 
Table 3. ITC Data for the Mn(II)- and Co(II)-Loaded H79A EcMetAP-I Enzymes 
  na Ka1, Ka2 (M−1) Kd1, Kd2 (μM) ΔH°1, ΔH°2 (kcal/mol) TΔS°1, TΔS°2 (kcal/mol) ΔG°1, ΔG°2 (kcal/mol) 
[CoCo(EcMetAP-I)] 1 6.36 × 105 1.6 15700 15708 −7.8 
  2 7.05 × 101 14200 1.1 × 106 1.1 × 106 −2.5 
[MnMn(EcMetAP-I)] 2 3.31 × 105 3.0 2600 2607 −7.4 
  1 2.27 × 102 4400 33800 33803 −3.2 
[CoCo(H79A)] 1 7.35 × 105 1.4 549 557 −7.9 
  2 6.41 × 102 1600 9770 9774 −3.8 
[MnMn(H79A)] 1 1.90 × 105 5.3 −461 −454 −7.1 
  2 1.34 × 104 80 20900 20905 −5.5 
aAll fits were performed using an n value of 3, providing two distinct binding events with individual n values of 1 and 2. 
The heat of reaction, measured during the ITC experiment, was converted into other thermodynamic 
parameters using the Gibbs free energy relationship: 
∆𝐺° =  −𝑅𝑇 ln(𝐾a)  =  ∆𝐻° −  𝑇∆𝑆° 
(10) 
The thermodynamic parameters obtained for titrations of Co(II) and Mn(II) into WT and H79A EcMetAP-I reveal 
changes that affect both of the metal binding sites (Table 3). Substitution of H79 with A makes the process of 
binding of the metal ions, particularly for the second metal ion, more spontaneous based on the more negative 
Gibbs free energies (ΔG). 
UV−Vis Spectra of Co(II)-Loaded H79A 
The electron absorption spectrum of H79A EcMetAP-I was recorded as a function of Co(II) concentration and 
compared to that of WT EcMetAP-I (Figure 4). For H79A EcMetAP-I, the addition of 1 equiv of Co(II) produced 
maxima at 520 nm (ε = 58 M−1 cm−1), 560 nm (ε = 72 M−1 cm−1), and 620 nm (ε = 34 M−1 cm−1). These absorption 
maxima are blue-shifted by ∼75 nm relative to those observed for WT EcMetAP-I. Upon addition of a second 
equivalent of Co(II) to H79A EcMetAP-I, the relative energies of all three observed maxima remained relatively 
constant; however, the molar absorptivities increased for each absorption band [520 nm (ε = 109 M−1 cm−1), 560 
nm (ε = 124 M−1 cm−1), and 620 nm (ε = 66 M−1 cm−1)]. The observed increase is consistent with both metal ions 
residing in five-coordinate environments (24). 
 
Figure 4. UV−vis spectra of H79A (−--−) and WT (—) EcMetAP-I in the presence of 1 and 2 equiv of Co(II). All 
spectra were recorded in 25 mM HEPES (pH 7.5) and 150 mM KCl. 
 
EPR Spectra of Co(II)- and Mn(II)-Loaded H79A 
The EPR spectrum of H79A EcMetAP-I to which 1 equiv of Co(II) was added {“[Co_(H79A EcMetAP-I)]”} provided 
an S = 3/2 species, with only the MS = |±1/2⟩ doublet populated from 6 to 60 K, and an essentially axial zero-field 
splitting (Figure 5A). The signal was very similar to, though distinguishable from, that of [Co_(WT EcMetAP-I)] 
(Figure 5C). Both EcMetAP-I signals displayed Curie law temperature dependence from 10 to 60 K. The observed 
EPR spectrum for [CoCo(H79A EcMetAP-I)] (Figure 5B) was indistinguishable from that of [Co_(H79A EcMetAP-I)] 
and also exhibited Curie law temperature dependence. This behavior mimicked that of the wild-type enzyme; 
the spectrum of [CoCo(WT EcMetAP-I)] and its temperature dependence were indistinguishable from those of 
[Co_(WT EcMetAP-I)]. Each of the spectra of Co(II) in the various forms of EcMetAP-I exhibited microwave 
power-dependent rapid passage effects below 10 K; comparison of the extent to which the finishing baseline of 
the first integral of spectra recorded at 8 K overshot the starting baseline indicated that the susceptibility to 
rapid passage effects was very similar for each of the species and that their relaxation properties were all, 
therefore, similar. 
 
Figure 5. X-Band EPR spectra of Co(II)-substituted forms of EcMetAP-I: (A) [Co_(H79A EcMetAPI)], (B) 
[CoCo(H79A EcMetAP-I)], and (C) [CoCo(WT EcMetAP-I)]. Spectra A and B were recorded at 8 K with a 0.2 mW 
microwave power; spectrum C was recorded at 9 K with a 0.2 mW microwave power. The amplitude of trace A is 
shown multiplied by 1.88 compared to spectrum B. The inset shows the spectra of [CoCo(H79A EcMetAP-I)] (D) 
and [CoCo(WT EcMetAP-I)] (E) overlaid. All the spectra were recorded at a field modulation amplitude of 1.2 mT, 
a modulation frequency of 100 kHz, and a sweep rate of 10.2 mT s−1, and the samples were in 25 mM HEPES 
buffer and 150 mM KCl (pH 7.5). 
 
The EPR spectra of [Mn_(H79A EcMetAP-I)] (Figure 6A,E) and [MnMn(H79A EcMetAP-I)] (Figure 6B,F) were 
indistinguishable from each other but were subtly different from the mutually indistinguishable spectra of 
[Mn_(WT EcMetAP-I)] (Figure 6C,G) and [MnMn(WT EcMetAP-I)] (Figure 6D,H). Close examination of the spectra 
(e.g., the expanded regions of Figure 6A) revealed no evidence of an ∼45 G (4.5 mT) pattern due to inter-Mn(II) 
spin coupling. In addition, spectra from both WT and H79A EcMetAP-I exhibited Curie law temperature 
dependence over a wide temperature range, and in contrast to WT EcMetAP-I, no additional transitions were 
observed when the temperature was increased to 60 K. The Mn(II) signals from WT EcMetAP-I were noticeably 
susceptible to rapid passage effects at low temperatures (6−8 K), while those of H79A EcMetAP-I were not, 
indicating somewhat different relaxation properties. 
 
Figure 6. X-Band EPR spectra of Mn(II)-substituted forms of EcMetAP-I: (A) [Mn_(H79A EcMetAP-I)], (B) 
[MnMn(H79A EcMetAP-I)], (C) [Mn_(WT EcMetAP-I)], and (D) [MnMn(WT EcMetAP-I)]. The high- and low-field 
wings of the spectrum of [Mn_(H79A EcMetAP-I)] are shown with a larger (5 times) amplitude, above and below, 
respectively, trace A. Traces E−H are of the geff ∼ 2 regions of spectra A−D, respectively. Spectra were recorded 
at 8 K with a microwave power of 0.2 mW, a field modulation amplitude of 1.2 mT, a modulation frequency of 
100 kHz, and a sweep rate of 10.2 mT s−1, and the samples were in 25 mM HEPES buffer and 150 mM KCl (pH 7). 
 
Discussion 
The active site histidine residues, H178 and H79, are strictly conserved in all MetAPs sequenced to date (6, 28). 
It has been suggested that both of these active site His residues play important roles in the catalytic removal of 
N-terminal methionine residues from polypeptide chains by MetAPs. While the catalytic role of H178 has been 
examined in some detail (1), the contributions of H79 to the hydrolysis reaction catalyzed by EcMetAP-I remain 
unclear. Several catalytic functions have been prescribed to H79, some of which are (1, 6, 19, 28, 37) (i) proper 
positioning of the substrate, (ii) stabilizing the transition state through hydrogen bond formation, (iii) hydrogen 
bonding to the backbone amide of the scissile peptide bond, and (iv) acting as a general acid by providing a 
proton to the backbone amide of the scissile peptide bond forming the new N-terminal amine (1, 6). To 
investigate the role of H79 in catalysis, we have generated the H79A EcMetAP-I enzyme and characterized this 
enzyme by kinetic and spectroscopic methods. 
The specific activity of the H79A-altered EcMetAP-I enzyme was determined in the presence of the tetrapeptide 
MGMM. Kinetic parameters for both Co(II)- and Mn(II)-loaded WT and H79A enzymes indicate that a significant 
amount of the observed effect on activity is due to a decrease in kcat. The kcat values for Co(II)- and Mn(II)-loaded 
H79A EcMetAP-I decreased by ∼6100- and ∼2.6-fold, respectively. Interestingly, the observed Km value for 
Co(II)-loaded H79A EcMetAP-I decreased ∼2-fold compared to that of WT EcMetAP-I; however, the 
observed Km value for Mn(II)-loaded H79A EcMetAP-I remained nearly identical to that of WT EcMetAP-I. 
Consequently, the resulting catalytic efficiency (kcat/Km) for Co(II)- and Mn(II)-loaded H79A EcMetAP-I decreased 
by ∼2900- and ∼3.5-fold, respectively. The more drastic loss of catalytic activity observed for the Co(II)-loaded 
H79A enzyme compared to the Mn(II)-loaded H79A enzyme highlights the differences in the preferred 
coordination geometry (i.e., five- vs six-coordinate) for Co(II)- versus Mn(II)-loaded EcMetAP-I enzymes. These 
data are also in line with previous studies on the Co(II)-loaded H79A-altered EcMetAP-I enzyme (19, 28). They 
are also consistent with those reported for the Co(II)-loaded H231N HsMetAP-II enzyme (H231 is equivalent to 
H79) in which a complete loss of activity was observed (37). 
To determine the effects of altering H79 on the metal binding properties of EcMetAP-I, the number of tightly 
bound metal ions and the Kd values for both metal binding sites were determined and compared to those of 
WT EcMetAP-I. On the basis of ICP-AES analysis, ∼1.0 metal ion is tightly associated with the H79A EcMetAP-I 
enzyme, as in WT EcMetAP-I (23). Similarly, both the Co(II)- and Mn(II)-loaded H79A EcMetAP-I enzymes 
exhibit Kd values identical, within error, to that of WT EcMetAP-I. These data confirm that H79 is not directly 
involved in binding of the first divalent metal ion. For H79A and WT EcMetAP-I, two additional weak metal 
binding events are also observed, the last of which is likely a remote Co(II) binding site identified in the X-ray 
crystal structure of EcMetAP-I (16, 20). This remote metal binding site, or third metal binding site, was also 
observed in the structure of HsMetAP-I (22). In both enzymes, this remote site is on the outer edge of the 
enzyme and becomes at least partially occupied at Co(II) concentrations near 1 mM. Interestingly, ITC data for 
the second Co(II) and Mn(II) binding events indicate that altering H79 to an Ala significantly increases the affinity 
of the second divalent metal ion binding site by factors of ∼10 and ∼25, respectively. The second β-sheet 
backbone of MetAP-I, which contains H79, also contains the active site ligands D108 and D97 which may perturb 
the metal ligating ability of those residues which are involved in binding the second divalent metal ion. 
The observed electronic absorption and EPR spectra of H79A with 1 and 2 equiv of Co(II) are similar to those of 
WT EcMetAP-I and are consistent with the X-ray crystal structure of H79A EcMetAP-I, which suggests that both 
Co(II) ions are pentacoordinate (19). The slight blue shift observed in the electronic absorption spectrum of 
Co(II)-loaded H79A EcMetAP-I versus WT EcMetAP-I is possibly due to the perturbation of the β-sheet peptide 
backbone that contains the metal ligands D108 and D97. Although the differences between the electronic 
absorption and EPR spectra of WT and H79A EcMetAP-I are slight, the very large difference in kcat between these 
species suggests that the structural origins of these spectroscopic differences have catalytic relevance. The Co(II) 
concentration-normalized intensities of EPR spectra obtained for [Co_(H79A EcMetAP-I)] and 
[CoCo(H79A EcMetAP-I)] were indistinguishable. As with the EPR spectra, the d−d region of the electronic 
absorption spectrum of H79A EcMetAP-I changed only in Co(II) concentration-dependent intensity upon 
addition of additional Co(II) to [Co_(H79A EcMetAP-I)]. Entirely analogous behavior has been reported for 
WT EcMetAP-I (23), and these data suggest that for both WT and H79A EcMetAP, the natures and relative 
proportions of the Co(II) environments do not change upon addition of up to 2 equiv of Co(II). 
Rationalization of these data with those obtained from ITC, kinetic, and X-ray crystallographic studies, at first, 
appears to be difficult. However, the most logical explanation leads to the conclusion that metal binding to 
MetAPs is cooperative and that discrepancies have arisen due to the concentrations of the enzyme samples 
used in the various experiments. For example, ITC data do not reveal cooperative binding of divalent metal ions 
to EcMetAP-I or PfMetAP-II but, instead, indicate that one metal ion binds with a much higher affinity than 
subsequent metal ions. It should be noted that ITC titrations are typically run with enzyme concentrations of 
∼70 μM, and most often reveal two sets of binding sites (23). Likewise, initial activity assays carried out 
on EcMetAP-I and PfMetAP-II used enzyme concentrations of ∼20 μM, a value 2 orders of magnitude larger than 
the Kd value determined for the first metal binding site of 0.2 or 0.4 μM assuming a Hill coefficient of 1.3 or 2.1, 
respectively (38, 39). However, a Kd value between 2.5 and 4.0 μM was reported if it was assumed that only a 
single Co(II) binding site exists in the low-concentration regime, which is within error of ITC and kinetic Kd values. 
Spectroscopic and most X-ray crystallographic measurements were carried out at much higher enzyme (∼1 mM) 
and metal concentrations, where a significant concentration of dinuclear sites will undoubtedly be present. 
Under the conditions utilized in ITC experiments, any cooperativity in divalent metal binding will not be 
detectable but may appear in EPR and electronic absorption data. Since activity titrations and ITC data are not 
particularly sensitive to the type of binding (i.e., cooperativity vs two independent binding sites), the weak 
cooperativity observed by Larrabee et al. (38) will not be observed in these experiments but is entirely 
consistent with the EPR and electronic absorption data and, indeed, with recent X-ray crystallographic data. 
Most X-ray structures of MetAPs were determined with a large excess of divalent metal ions, so only dinuclear 
sites are observed. However, crystallographic data obtained for EcMetAP-I using metal ion:enzyme ratios of 
0.5:1 reveal metal ion occupancies of 71% bound to the M1 site and 28% bound to the M2 site, consistent with 
cooperative binding (25). 
While studies on the Co(II) form of MetAP may provide some mechanistic insight, Mn(II) or Fe(II) is more likely 
the physiological metal ion (29, 40, 41). EPR spectra obtained with 1 and 2 equiv of Mn(II) were indistinguishable 
(apart from intensity) and, similar to Co(II), suggest cooperativity in binding under the conditions that were 
employed. EPR spectra recorded on the Mn(II)-loaded H79A EcMetAP-I enzyme suggested that the Mn(II) ions 
reside in a mixed oxygen/nitrogen coordination environment, as in the WT enzyme (42). However, in contrast to 
WT EcMetAP-I and the type II MetAP from P. furiosus, no evidence of inter-Mn(II) spin coupling was observed for 
the Mn(II)-loaded H79A EcMetAP-I enzyme from either parallel mode EPR, temperature dependence, or close 
examination of the spectra for a 45 G hyperfine pattern. In addition, the relaxation behaviors of Mn(II) in the WT 
and H79A enzymes differed. These data suggest subtle differences in the architecture of the dinuclear site in the 
WT versus H79A enzyme, possibly pertaining to a bridging ligand that, in WT EcMetAP-I, mediates exchange 
coupling between the Mn(II) ions. That H79A EcMetAP-I is only 2.5-fold less active than the WT enzyme 
suggests, in turn, that the putative bridging ligand is unimportant for activity and is, therefore, unlikely to be the 
source of the nucleophile. 
A fundamental aspect of the catalytic mechanism of MetAPs that has not been addressed to date is the chemical 
identity of the rate-limiting step. Kinetic isotope effect studies are an excellent way of gaining an understanding 
of the nature of the rate-limiting step as well as probing the transition state of catalytic reactions (43). Primary 
isotope effects are observed if a bond to the labeled atom is made or broken during the reaction, whereas 
secondary isotope effects describe processes at other positions. Therefore, we examined the solvent isotope 
effect of WT and H79A EcMetAP-I using MGMM as the substrate at pH 7.6 (31) by substituting hydrogen (1H) 
with deuterium (2H). The presence of D2O lowers the catalytic activity of both WT and H79A EcMetAP-I, resulting 
in solvent isotope effects of 1.6 and 1.5, respectively. This is similar to the solvent isotope effect observed for 
carboxypeptidase A (1.3) (44), the aminopeptidase from Aeromonas proteolytica (2.8) (45), and the β-lactamase 
from Bacteriodes fragilis (2.6) (46). These results are consistent with a proton being transferred in the rate-
limiting step of the reaction. Since the fractionation factor (ϕ) is characteristic of a proton−oxygen bond (neutral 
oxygen, 0.8−1.2) with a conventional isotope effect equal to 1 (33), the ϕ value of 0.80 suggests that an O−H 
bond is broken in the rate-limiting step. Since the rate-limiting step in peptide hydrolysis has previously been 
shown to be product formation (47), this may represent the protonation of the leaving group by a proton 
obtained from the hydroxide that reorganizes to a carbonyl group in the transition state after attacking the 
scissile peptide bond leading to the collapse of the transition state (Figure 7). Both WT and H79A EcMetAP-I 
exhibit similar solvent isotope effects, suggesting that H79 is not involved in the transfer of a proton during 
catalytic turnover. Therefore, its function is likely limited to stabilization of the transition state by hydrogen 
bonding which facilitates the formation of the leaving group. These data are consistent with the proposed 
catalytic mechanism for MetAP and indicate that proton transfer processes limit the catalytic reaction (Figure 7). 
 
Figure 7. Proposed catalytic mechanism for MetAPs assuming cooperative metal binding. 
 
In summary, several catalytic mechanisms for EcMetAP-I have been proposed (19, 26) on the basis of kinetic, 
spectroscopic, X-ray crystallographic, and molecular modeling studies. In all of these mechanisms, donation of a 
proton by E204 or H79 to the leaving group amino nitrogen was proposed to cause the collapse of the transition 
state into the corresponding products. However, on the basis of data presented herein, H79 does not transfer a 
proton to the newly forming amine since a single proton is transferred in the transition state for both WT and 
H79A EcMetAP-I (Figure 7). Therefore, H79 is not essential as a general acid during catalysis, which suggests that 
the single observed proton transfer is likely due to E204 transferring a proton to the peptide backbone amide. 
The starkly different effects of H79A substitution on the catalytic activities of Mn(II)- and Co(II)-
containing EcMetAP-I suggest that the role of H79 is dependent on some property of the metal ion that is not 
shared by Co(II) and Mn(II). Where Co(II) is five-coordinate in EcMetAP-I, Mn(II) prefers six-coordinate 
geometries. A role for H79 in positioning the substrate, by hydrogen bonding to either the amine group of the 
peptide linkage or a backbone carbonyl group, would indeed cause the catalytic efficiency to be very sensitive to 
the geometry of the metal ion. Analogues of both of these putative interactions between H79 and substrate 
have been observed in X-ray crystallographic studies with inhibitors (6). This role is also consistent with the 
observed differences in activity for different length peptides as well as the observed difference in kcat values for 
Co(II)- versus Mn(II)-loaded H79A enzymes. 
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